A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

NCT05453578 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Bacterial Disease Carrier
Cystic Fibrosis

Interventions

OTHER: Placebo
BIOLOGICAL: WRAIR-PAM-CF1

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)